news, journals and articles from all over the world.
As older teens and young adults become eligible for COVID-19 vaccination across the country, and younger teens await their turn, new survey data suggest a strong readiness that has grown since fall. But just as with older generations, a shrinking but still sizable minority of people age 14 to 24 say they’re not willing to get vaccinated, or that their decision will depend on safety.
Read moreA slightly lighthearted guide to post-vaccination life, including how to help others who haven’t gotten vaccinated yet.
Read moreWomen who were vaccinated for COVID-19 earlier in their third trimester had a higher likelihood of passing protective antibodies to their newborn babies than women who received their vaccination closer to delivery, a new study from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has found.
Read moreFewer than half of inmates in jails and prisons surveyed in a study by the CDC and University of Washington said they would accept a COVID-19 vaccine, while the majority either said they wanted to wait before getting the vaccine or would refuse one.
Read moreEarly on in the COVID-19 pandemic, celebrities were as active as government and health officials in spreading the word about
Read moreA new report shows parents are more vaccine hesitant and resistant than non-parents (in terms of willingness to vaccinate themselves) across all socioeconomic and demographic groups compared. This pattern is largely driven by younger mothers, who are far more vaccine resistant than younger women who are not mothers. Older parents and fathers show little difference from their non-parent peers.
Read more
Nick Pullen, Ph.D., an associate professor of Biological Sciences at the University of Northern Colorado, shares his expertise on the COVID-19 vaccines and debunks some of the myths surrounding them.
Read moreA new SARS-CoV-2 vaccine candidate, developed by giving a key protein’s gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.
Read moreAs COVID-19 vaccines continue to be distributed, the world’s leading bone health research, clinical, and patient advocacy organizations ASBMR, Endocrine Society, AACE, ECTS, NOF, and IOF provide recommendations to assist clinicians in managing osteoporosis treatments for their patients who plan to get vaccinated. The full guidance document with supporting evidence is available at https://www.asbmr.org/about/statement-detail/joint-guidance-on-covid-19-vaccine-osteoporosis
Read moreDespite CDC recommendations that farmworkers should be one of the first groups selected for COVID-19 vaccinations, some of the top
Read moreA new article published online in the Journal of the American College of Radiology (JACR®) explains how patients recently vaccinated for COVID-19 can experience false-positive imaging exams and outlines steps providers can take to reduce unwarranted follow-up care for these findings.
Read more
After a year of racial unrest due to the killing of unarmed Black men and women and the upending of our regular lives due to the COVID-19 pandemic, many have forged a new outlook on life. Two Black Rutgers female faculty share their reflections on the past year and their hopes for the future.
Read moreA study from Michigan State University that found in spite of Black Americans’ attitudes toward proper precautions, they are disproportionately impacted by the pandemic and White people are less likely to fall ill.
Since the first cases of COVID-19 were reported in the U.S. more than a year ago, board-certified dermatologist Esther Freeman,
Read moreThe Mount Sinai Health System is joining medical centers across the United States in a grassroots effort to encourage public participation in vaccinations against COVID-19.
Read more
Supporting its mission of public service, the CSU is hosting COVID vaccination clinics statewide to help end the pandemic.
Read moreThe American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.
Read more
Kinks in new production and distribution supply chains are why COVID-19 vaccines approved for use in the United States have been sluggish finding their way into people’s arms, says an expert in logistics and supply chains at The University of Alabama in Huntsville (UAH), a part of the University of Alabama System.
Read moreThe testing plan for the “British variant” is based on findings of pre-clinical tests showing stenoparib blocks infection and the replication of SARS-CoV-2, as recently published in peer-reviewed journal mBio.
Read moreThe National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
Read moreUniversity of Maryland Professor Emeritus Michael O. Ball, a researcher and expert on supply chain management and system reliability, is
Read moreLifeBridge Health has begun to administer the COVID-19 vaccine to front-line healthcare workers. The first doses of the newly approved Pfizer COVID vaccine arrived at LifeBridge Health on December 17 with 24 team members receiving the vaccine that afternoon at Sinai Hospital.
Read more
With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.
Read more
A new poll of adults ages 50 to 80 suggests that achieving the widespread vaccination against COVID-19 needed to protect this high-risk group and end the pandemic will be an uphill climb, and require clear, transparent communication from health providers and others.
Read more
The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.
Read moreA Rutgers public health expert is available to discuss Pfizer’s vaccine, which has shown to be effective according to recent
Read moreThe Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood
Read moreAnnouncement of University Hospitals plans to participate as a site for the Phase 2/3 global study sponsored by Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) of an investigational vaccine, BNT162b2, against SARS-CoV-2.
Read more
Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than
Read moreBy: Mark Blackwell Thomas | Published: May 14, 2020 | 12:36 pm | SHARE: As the number of COVID-19 cases in the U.S. continues to increase, one Florida State University researcher said the number of people looking to profit from the misfortune by offering false, unproven cures is also on the rise. There is no known cure for COVID-19 but Chad Marzen, associate professor of law in the FSU College of Business, said that hasn’t stopped opportunists from looking to capitalize off people’s fears.
Read more